What is the AI-Powered Embryo Selection Market Size in 2026?
The global AI-powered embryo selection market size accounted for USD 320.00 million in 2025 and is predicted to increase from USD 379.20 million in 2026 to approximately USD 1,747.16 million by 2035, expanding at a CAGR of 18.50% from 2026 to 2035. The market is driven by ongoing advancements in machine learning, increasing success rates in IVF treatments, and the rising demand for personalized fertility solutions.
Key Takeaways
- North America led the AI-powered embryo selection market in 2025 with a 40% share.
- The Asia Pacific is observed to grow at the highest CAGR of 21% between 2026 and 2035.
- By component, the software segment led the market with 65% share in 2025.
- By component, the services segment is observed to grow at a CAGR of about 17% in the upcoming period.
- By technology, the deep learning segment dominated the global market in 2025 with a 45% and is expected to grow at the fastest CAGR over the forecast period.
- By application, the in vitro fertilization segment led the global market in 2025 with a 50% share.
- By application, the embryo viability assessment segment is expected to expand at the fastest CAGR of 20% in the coming years.
- By end-use, the fertility clinics segment led the global market in 2025 with 60% share and is expected to grow at the fastest CAGR of 18.8% in the coming years.
AI-Powered Embryo Selection Market Overview
Artificial intelligence and machine learning technologies are transforming the approach to infertility treatment . AI-driven embryo selection enables embryologists to identify the most viable embryos for IVF by providing more precise and objective evaluations of embryo viability. By analyzing extensive datasets of embryo images and developmental patterns, AI systems can detect subtle characteristics and have the potential to improve prediction accuracy compared to conventional techniques. This advancement contributes to higher IVF success rates while reducing the emotional and financial burden on patients.
Tools such as iDAScore, ERICA, and Life Whisperer are among the most widely used. These AI solutions deliver comprehensive image-based analyses of each embryo and examine their features to generate an AI score, helping embryologists select the highest-quality embryos for the IVF process.
AI-Powered Embryo Selection Market Trends
- Growing Integration of AI-enabled Telehealth in Fertility Care: The integration of AI-powered embryo selection with a telehealth platform is enabling remote consultation, data sharing, and improved decision-making, enhancing accessibility and efficiency in IVF treatments.
- Emergence of Patient-Centered Digital Platforms: Patient-centered digital platforms are emerging, allowing clinics to analyze embryo data, track treatment progress, and enhance decision-making, improving overall efficiency in fertility treatment.
- Growing Strategic Partnership in Fertility Tech: Partnership between AI developers, fertility clinics, and IVF technology providers is advancing intelligent embryo acceleration data-driven fertility solutions
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 320.00 Million |
| Market Size in 2026 | USD 379.20 Million |
| Market Size by 2035 | USD 1,747.16 Million |
| Market Growth Rate from 2026 to 2035 | CAGR of 18.50% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Component, Technology, Application, End Use, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Regional Insights
North America is a leading region in the AI-powered embryo selection market due to its advanced healthcare infrastructure and high adoption of assisted reproductive technologies (ART). The region has a strong presence of fertility clinics, research institutions, and technology providers integrating AI into IVF procedures. Increasing awareness about infertility treatments, delayed parenthood trends, and a growing focus on improving IVF success rates are driving the adoption of AI-based embryo selection tools. Supportive regulatory frameworks and continuous innovation in AI-driven healthcare solutions further boost market growth.
Europe is also a significant market, supported by well-established fertility care systems and rising demand for advanced reproductive technologies. Countries across the region are focusing on improving IVF outcomes through the use of AI and data-driven approaches. Ethical considerations and strict regulations around reproductive technologies influence the adoption of AI solutions, but they also ensure high standards of safety and transparency. Increasing collaborations between fertility clinics and AI companies are contributing to steady market expansion.
Asia-Pacific is experiencing rapid growth in this market, driven by increasing infertility rates, rising healthcare awareness, and expanding access to fertility treatments. Countries like China, India, Japan, and South Korea are investing in advanced reproductive technologies, including AI-powered embryo selection. A large population base, growing medical tourism, and improving healthcare infrastructure are key factors supporting market growth. Additionally, the rising affordability of IVF treatments in some countries is encouraging wider adoption.
Latin America is gradually adopting AI-powered embryo selection technologies as fertility services continue to expand in the region. While the market is still developing, there is growing demand for improved IVF success rates and advanced treatment options. Increasing awareness, private sector investments, and partnerships with international healthcare providers are helping to drive adoption in key countries.
Middle East & Africa is an emerging market with growing interest in fertility treatments and advanced medical technologies. Some countries in the Middle East are investing in high-quality fertility clinics and adopting AI-driven solutions to enhance treatment outcomes. In Africa, adoption is still at an early stage but is expected to grow as healthcare infrastructure improves and awareness of fertility solutions increases. The demand for effective and efficient reproductive treatments is expected to support future market growth.
AI-Powered Embryo Selection Market Key Players
- Vitrolife AB
- CooperSurgical Inc.
- Genea Biomedx
- Fairtility Ltd.
- Alife Health Inc.
- Overture Life
- AIVF (Artificial Intelligence IVF)
- iGenomix (Vitrolife Group)
- Merck KGaA
- Fujifilm Irvine Scientific
- Hamilton Thorne Ltd.
- Nikon Corporation
- ZEISS Group
- Esco Medical
- LabIVF Asia
Recent Developments
- In August 2025, Nova IVF Fertility, a leading IVF center chain, announced a major enhancement to its fertility treatment services by integrating artificial intelligence (AI) into its IVF laboratories to improve precision and transparency in embryo selection.
- In October 2025, Life Health’s AI-powered embryo selection tool, Embryo Predict, received CE Mark certification under the European Medical Device Regulation (MDR).
Segments Covered in the Report
By Component
- Software
- Services
By Technology
- Machine Learning
- Deep Learning
- Computer Vision
By Application
- In Vitro Fertilization (IVF)
- Genetic Screening
- Embryo Viability Assessment
- Others
By End-Use
- Fertility Clinics
- Hospitals
- Research Institutes
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
Get Sample Link: https://www.precedenceresearch.com/sample/8295
Also Read : https://www.businesswebwire.com/ai-in-omics-studies-market/